Jansen P L, Müller M, Kuipers F
Afd. Maag-, Darm- en Leverziekten, Academisch Ziekenhuis, Hanzeplein 1, 9713 GZ Groningen.
Ned Tijdschr Geneeskd. 2000 Dec 9;144(50):2384-91.
Transport proteins in hepatocytes and bile duct epithelium mediate uptake and secretion of cholephilic compounds in the liver and are involved in bile formation. Many of these proteins have recently been cloned and characterized and appear to belong to large gene families. Apart from the liver these proteins are expressed in the blood-brain barrier, placenta, kidneys, lungs, intestine and seminiferous tubules. Prokaryotes and yeasts contain similar proteins. In cancer cells they are involved in multidrug resistance. Some genetic cholestatic liver diseases, including progressive familial intrahepatic cholestasis, Dubin-Johnson syndrome, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy result from mutations in transport protein genes. These proteins also play a role in drug-induced liver disease and in primary biliary cirrhosis. Cyclosporine and oestradiol (glucuronide) for instance inhibit bile salt export protein (BSEP).
肝细胞和胆管上皮细胞中的转运蛋白介导肝脏中亲胆化合物的摄取和分泌,并参与胆汁形成。最近,其中许多蛋白质已被克隆和表征,似乎属于大型基因家族。除肝脏外,这些蛋白质还在血脑屏障、胎盘、肾脏、肺、肠道和生精小管中表达。原核生物和酵母含有类似的蛋白质。在癌细胞中,它们与多药耐药性有关。一些遗传性胆汁淤积性肝病,包括进行性家族性肝内胆汁淤积症、杜宾-约翰逊综合征、良性复发性肝内胆汁淤积症和妊娠期肝内胆汁淤积症,是由转运蛋白基因突变引起的。这些蛋白质在药物性肝病和原发性胆汁性肝硬化中也起作用。例如,环孢素和雌二醇(葡萄糖醛酸苷)会抑制胆盐输出蛋白(BSEP)。